Dual Task Aerobic Exercise for Older Adults With Cognitive Impairment (HM2) (HM2)

October 24, 2014 updated by: Robert Petrella, MD, Parkwood Hospital, London, Ontario

Study of Community Based Dual Task and Aerobic Exercise Intervention on Cognition and Mobility in Older Adults Without Dementia

The investigators proposed research will establish whether combining aerobic exercise with cognitive challenges is feasible and effective in community dwelling older adults with early signs of cognitive impairment.

Study Overview

Detailed Description

To determine the effects of dual-task aerobic exercise training on community dwelling older adults with early signs of cognitive impairment. We will compare an exercise intervention (E-I) versus an exercise control (E-C) group. Each week, both groups will accumulate a minimum of 120 minutes of exercise (target 150 minutes) from community-based group classes (50 minutes of aerobic exercise) and also complete 45 minutes of beginner-level Square Stepping Exercise (SSE). The E-I group will also answer cognitively challenging questions while doing SSE (dual-task training). This study will determine whether a combined multiple modality (primary component being aerobic exercise) and dual-task exercise program is both feasible and effective for improving cognitive and mobility status, as well as vascular compliance, in older adults who may be at risk for cognitive and mobility decline.

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • London, Ontario, Canada, N6C 5J1
        • Aging, Rehabilitation and Geriatric Care Research Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male/Female 55-90 years old.
  • Montreal Cognitive Assessment score ≤27
  • Preserved Instrumental Activities of Daily Living (based on Lawton-Brody Instrumental Activities of Daily Living Sale)

Exclusion Criteria:

  • Dementia (i.e., Mini-Mental Examination score <24 or self-reported physician diagnosis)
  • Major Depression (>=16 on the Center for Epidemiologic Studies - Depression Scale combined with clinical judgment by primary study physician)
  • Other neurological or psychiatric disorders
  • Recent history of severe cardiovascular conditions
  • Significant orthopedic conditions
  • Have blood pressure >180/100 mmHg or <100/60 mmHg
  • Unable to comprehend questionnaire material/study procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise Intervention Group
For 26 weeks, attend Canadian Centre for Activity and Aging combined classes (75-minute or 60-minute classes, 2 to 3 days/week) and also complete 45 minutes of dual-task gait training (15 minutes for 3 days/week or 22.5 minutes for 2 days/week)
Goal of 150 minutes of structured exercise/week; minimum of 120 minutes from CCAA classes/week. The 75-minute class includes: 5-minute warm-up; 25 minutes of AE (70-85% maximum heart rate); 5-minute cool-down; 20 minutes of strength training; 5 minutes of core strengthening; 5 minutes of balance training; and 10 minutes of stretching. The 60-minute program is identical except: 15 minutes total for all strength training (including core) and 5 minutes of stretching. Following CCAA classes, participants continue with dual-task gait training where they are required to walk on a special mat with a designated walking pattern (beginner level Square Stepping Exercise) while answering cognitively challenging questions.
Other Names:
  • Aerobic exercise and dual-task training
Active Comparator: Exercise Control group
For 26 weeks, attend Canadian Centre for Activity and Aging combined classes (75-minute or 60-minute classes, 2 to 3 days/week) and also complete 45 minutes of gait training (15 minutes for 3 days/week or 22.5 minutes for 2 days/week). Note: no dual-task challenges during gait training
Goal of 150 minutes of structured exercise/week; minimum of 120 minutes from CCAA classes/week. The 75-minute class includes: 5-minute warm-up; 25 minutes of AE (70-85% maximum heart rate); 5-minute cool-down; 20 minutes of strength training; 5 minutes of core strengthening; 5 minutes of balance training; and 10 minutes of stretching. The 60-minute program is identical except: 15 minutes total for all strength training (including core) and 5 minutes of stretching. Following CCAA classes, participants continue with gait training where they are required to walk on a special mat with a designated walking pattern (beginner level Square Stepping Exercise). This will not include any dual-task challenges.
Other Names:
  • Aerobic exercise and gait training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Global cognitive functioning
Time Frame: 26 weeks
Four standardized domain-specific composite scores were averaged to create this standardized global cognitive functioning score (incorporates executive function, processing speed, verbal learning and memory, and verbal fluency.
26 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Global cognitive functioning
Time Frame: 12 & 52 weeks
Four standardized domain-specific composite scores were averaged to create this standardized global cognitive functioning score (incorporates executive function, processing speed, verbal learning and memory, and verbal fluency.
12 & 52 weeks
Executive Function/Mental Flexibility
Time Frame: 12, 26, and 52 weeks
Standardized scores from seconds to complete Trail Making Test Part A and Trail Making Test Part B averaged to create this standardized composite score
12, 26, and 52 weeks
Processing Speed
Time Frame: 12, 26 and 52 weeks
Standardized score from the Digit-Symbol Substitution Test (total correct responses)
12, 26 and 52 weeks
Verbal Learning and Memory
Time Frame: 12, 26 and 52 weeks
Standardized scores from Auditory Verbal Learning Test (number of words learned and number of words recalled) were averaged to create this standardized composite score
12, 26 and 52 weeks
Verbal Fluency
Time Frame: 12, 26 and 52 weeks
Standardized scores from semantic (number of animals) and phonemic (number of words starting with C) were averaged to create this standardized composite score
12, 26 and 52 weeks
Gait variability (step length) under dual-task conditions
Time Frame: 12, 26 and 52 weeks
Gait variability is the stride-to-stride fluctuations of the way someone walks and will be calculated as coefficient of variation of step length (SD/mean x 100). Measured with GAITRite system.
12, 26 and 52 weeks
Gait variability (step length) under single-task conditions
Time Frame: 12, 26 and 52 weeks
Gait variability is the stride-to-stride fluctuations of the way someone walks and will be calculated as coefficient of variation of step length (SD/mean x 100). Measured with GAITRite system.
12, 26 and 52 weeks
Gait speed under dual-task conditions
Time Frame: 12, 26 and 52 weeks
Average walking speed measured with GAITRite system
12, 26 and 52 weeks
Gait speed under single-task conditions
Time Frame: 12, 26 and 52 weeks
Average walking speed measured with GAITRite system
12, 26 and 52 weeks
Double support (seconds and % gait cycle time) under dual-task conditions
Time Frame: 12, 26 and 52 weeks
Initial double support occurs from heel contact of one footfall to toe-off of the opposite footfall. Terminal double support occurs from opposite footfall heel strike to support footfall toe-off.Total double support is the sum of the initial double support added to the terminal double support. It is measured in seconds (sec) and also expressed as a percent of the Gait Cycle time for the same foot. Measured with GAITRite system
12, 26 and 52 weeks
Double support (seconds and % gait cycle time) under single-task conditions
Time Frame: 12, 26 and 52 weeks
Initial double support occurs from heel contact of one footfall to toe-off of the opposite footfall. Terminal double support occurs from opposite footfall heel strike to support footfall toe-off.Total double support is the sum of the initial double support added to the terminal double support. It is measured in seconds (sec) and also expressed as a percent of the Gait Cycle time for the same foot. Measured with GAITRite system
12, 26 and 52 weeks
Step length under dual-task conditions
Time Frame: 12, 26 and 52 weeks
Mean step length measured with GAITRite system
12, 26 and 52 weeks
Step length under single-task conditions
Time Frame: 12, 26 and 52 weeks
Mean step length measured with GAITRite system
12, 26 and 52 weeks
Carotid artery compliance
Time Frame: 12, 26 and 52 weeks
Measured from non-invasive vascular assessment with B-mode Ultrasound over the carotid artery (in the neck)
12, 26 and 52 weeks
Carotid artery Intima-media thickness (IMT)
Time Frame: 12, 26 and 52 weeks
Measured from non-invasive vascular assessment with B-mode Ultrasound over the carotid artery (in the neck)
12, 26 and 52 weeks
Ambulatory systolic blood pressure
Time Frame: 12, 26 and 52 weeks
Average systolic blood pressure over a 24-hour time frame
12, 26 and 52 weeks
Clinic systolic blood pressure
Time Frame: 12, 26 and 52 weeks
Average systolic blood pressure from final 2 (out of 3) readings
12, 26 and 52 weeks
Ambulatory diastolic blood pressure
Time Frame: 12, 26 and 52 weeks
Average diastolic blood pressure over a 24-hour time frame
12, 26 and 52 weeks
Clinic diastolic blood pressure
Time Frame: 12, 26 and 52 weeks
Average diastolic blood pressure from final 2 (out of 3) readings
12, 26 and 52 weeks
Total balance score
Time Frame: 12, 26, and 52 weeks
Total balance score calculated from the Fullerton Advanced Balance Scale
12, 26, and 52 weeks
Total Falls Self-Efficacy score
Time Frame: 12, 26, and 52 weeks
Total falls self-efficiacy score calculated from the Falls Self-Efficacy International (FES-I) scale
12, 26, and 52 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Robert J Petrella, MD., PhD., Lawson Health Research Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2012

Primary Completion (Actual)

November 1, 2013

Study Completion (Actual)

May 1, 2014

Study Registration Dates

First Submitted

April 3, 2012

First Submitted That Met QC Criteria

April 5, 2012

First Posted (Estimate)

April 6, 2012

Study Record Updates

Last Update Posted (Estimate)

October 28, 2014

Last Update Submitted That Met QC Criteria

October 24, 2014

Last Verified

October 1, 2014

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Impairment

Clinical Trials on Exercise Intervention

3
Subscribe